导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.23% | 171/350 |
| 近一周 | -0.29% | 12/358 |
| 近一月 | -0.73% | 70/358 |
| 近一季 | 2.06% | 74/358 |
| 近半年 | 3.55% | 172/354 |
| 近一年 | 10.63% | 142/345 |
| 近两年 | 28.44% | 178/310 |
| 近三年 | 44.14% | 110/242 |
| 成立以来 | 50.78% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.43% 64/360 |
1.73% 173/366 |
- - |
- - |
| 2025 | 25.97% 62/358 |
8.40% 121/340 |
6.57% 168/348 |
4.03% 303/354 |
4.82% 32/358 |
| 2024 | 7.82% 198/329 |
2.85% 5/12 |
- - |
4.45% 175/318 |
-3.16% 199/329 |
| 2023 | 10.81% 81/275 |
2.74% 90/205 |
6.19% 89/230 |
-2.40% 33/262 |
4.07% 144/276 |
| 2022 | 9.62% 10/201 |
4.76% 12/153 |
-3.37% 69/164 |
-3.85% 58/189 |
12.63% 75/202 |
| 2021 | 14.18% 54/150 |
6.35% 52/312 |
4.14% 148/328 |
-0.55% 112/358 |
3.66% 65/151 |
| 2020 | -17.36% 78/103 |
-22.39% 222/280 |
3.73% 246/295 |
-6.48% 278/299 |
9.75% 129/305 |
| 2019 | 15.33% 53/88 |
8.54% 148/258 |
3.13% 86/268 |
-2.69% 191/253 |
5.88% 143/266 |
| 2018 | -10.46% 51/79 |
- - |
- - |
- - |
-17.00% 186/241 |
| 2017 | 11.26% 45/69 |
- - |
- - |
- - |
- - |
| 2016 | 14.80% 9/59 |
- - |
- - |
- - |
- - |
| 2015 | -24.59% 42/49 |
- - |
- - |
- - |
- - |
| 2014 | -10.48% 88/99 |
- - |
- - |
- - |
- - |
| 2013 | 4.73% 37/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2946 | 31.47% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3488 | 29.79% |
| 汇添富恒生生物科技ETF(QDII) | 1.1245 | 29.24% |
| 南方恒生生物科技ETF(QDII) | 1.1400 | 29.08% |
| 广发道琼斯石油指数美元现汇A | 0.4638 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4557 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4568 | 27.33% |
| 南方恒生生物科技ETF发起联接(QDII)A | 1.2646 | 27.30% |
| 华夏恒生生物科技ETF发起式联接(QDII)C | 1.1472 | 27.25% |
| 汇添富恒生生物科技ETF发起式联接(QDII)C | 1.6358 | 27.22% |